Metabolome and transcriptome integration reveals metabolic profile of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Metabolome and transcriptome integration reveals metabolic profile of hepatocellular carcinoma

Published:2022-11 Issue:12 Volume:37 Page:2321-2330
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J of Gastro and Hepatol

Author:

Hou Guojun¹,Xu Wenfang²,Ding Dongyang¹,Tian Tao¹,Liu Gang²,Yang Yuan¹^ORCID,Liu Hui¹^ORCID,Zhou Weiping¹

Affiliation:

1. The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital Second Military Medical University Shanghai China

2. Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences and Institutes of Biomedical Sciences Fudan University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.16024

Reference42 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Marginal survival benefit in the treatment of early hepatocellular carcinoma

3. Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment

4. Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic phenotyping combined with transcriptomics metadata fortifies the diagnosis of early-stage Hepatocellular carcinoma;Journal of Advanced Research;2024-09

2. Association between 91 inflammatory factors combined with 1400 metabolites and ankylosing spondylitis: a two-sample Mendelian randomization study;2024-03-27

3. Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment;Pharmacological Research;2023-03